Chemoinformaics analysis of Methyl tetradeca-2,4-dienoate
| Molecular Weight | 238.371 | nRot | 10 |
| Heavy Atom Molecular Weight | 212.163 | nRig | 3 |
| Exact Molecular Weight | 238.193 | nRing | 0 |
| Solubility: LogS | -4.782 | nHRing | 0 |
| Solubility: LogP | 5.065 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 43.9906 |
| nHD | 0 | BPOL | 28.6874 |
| QED | 0.32 |
| Synth | 2.463 |
| Natural Product Likeliness | 1.47 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.132 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.578 |
| MDCK | 0.0000237 |
| BBB | 0.947 |
| PPB | 0.960129 |
| VDSS | 0.832 |
| FU | 0.0363867 |
| CYP1A2-inh | 0.965 |
| CYP1A2-sub | 0.65 |
| CYP2c19-inh | 0.723 |
| CYP2c19-sub | 0.752 |
| CYP2c9-inh | 0.446 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.549 |
| CYP3a4-inh | 0.744 |
| CYP3a4-sub | 0.216 |
| CL | 5.67 |
| T12 | 0.706 |
| hERG | 0.137 |
| Ames | 0.026 |
| ROA | 0.551 |
| SkinSen | 0.978 |
| Carcinogencity | 0.59 |
| EI | 0.943 |
| Respiratory | 0.96 |
| NR-Aromatase | 0.254 |
| Antiviral | Yes |
| Prediction | 0.783719 |